Migranal

   
Google
 
Web NewDrugInformation.com

Migranal


Drug - Migranal
The trade name of the product as shown on the labeling.

Dosage - SPRAY, METERED; NASAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Dihydroergotamine Mesylate
Multiple ingredients are in alphabetical order.

Strength - 0.5MG/INH
The potency of the active ingredient(s), Dihydroergotamine Mesylate. May repeat for multiple part products.

Applicant - VALEANT
The firm name holding legal responsibility for Migranal. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 020148
The FDA assigned number to Migranal. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Migranal. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Dec 8, 1997
The date Migranal was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - Yes
The pioneer or innovator of Migranal. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Migranal is in. Format is RX, OTC, DISCN.

Applicant Full Name - Valeant Pharmaceuticals International
The full name of the firm holding legal responsibility for the new application of Migranal.

Migranal